Receive The Newest Study Notifications

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the submission of its multi-site European pivotal clinical trial data for the EVO+ Visian® ICL with...

MDNA19 demonstrates robust efficacy and safety with or without checkpoint inhibitors in preclinical models; Clinical studies expected to commence in 2020 Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") (TSX: MDNA,OTCQB: MDNAF), a clinical stage...

The completed trial, which now includes data from elderly volunteers receiving repeated doses, continues to demonstrate that the drug was safe and well-tolerated, with adverse event rates comparable to placebo Alterity Therapeutics Limited has announced that it has...

ATI-501 achieved statistically significant improvement over placebo in several measures of hair growth, including the primary endpoint and certain secondary endpoints of the trial. ATI-501 was generally well-tolerated at all doses.  No serious adverse events or...

  -- Diroximel Fumarate Demonstrated Statistically Superior Gastrointestinal (GI) Tolerability on EVOLVE-MS-2 Study's Primary Endpoint Assessing Self-Reported GI Events -- -- Discontinuations Due to GI Events were Less than 1% for Diroximel Fumarate -- Alkermes...

Data from second part of successful Phase 2 STRIVE trial further substantiate the efficacy, safety and tolerability of once-weekly rezafungin for first-line treatment of invasive Candida infections Global Phase 3 ReSTORE trial ongoing Company to host conference call...

The University of California, Berkeley announced today that it has received a five-year grant expected to total $47 million from the U.S. National Institute on Aging (NIA) to incorporate advanced brain imaging into the Alzheimer's Association's groundbreaking clinical...

Next generation platform features greater auditability, on-prem capabilities, and new Actigraph integration Litmus Health, the research-ready infrastructure platform for real world data, today announced the release of the next generation of their platform, focused on...

--Reflow Medical, Inc. announces that the first patients have been enrolled in its DEEPER OUS clinical trial using the Temporary Spur Stent System. DEEPER OUS is a 100-patient prospective, non-randomized, multicenter trial designed to assess the safety and efficacy of...

Mark Terry for Biospace writes: A number of companies reported clinical trial data last week. Here’s a look. Takeda Pharmaceutical’s VISIBLE 2 Phase III clinical trial in Crohn’s disease hit its primary endpoints. The trial evaluated Entyvio (vedolizumab) as a...

Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial matching, announces today its newly developed “Hub” aimed to build strategic partnerships with some of the most prominent Just-In-Time (JIT)...

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) today announced that it has successfully completed its Phase 1 study of PBT434, a novel, orally bioavailable small molecule inhibitor of alpha- synuclein aggregation. Alpha-synuclein,...

One of the shining lights in mesothelioma research can be found at the Baylor College of Medicine Lung Institute, where the Houston-based center’s Mesothelioma Treatment Center has long been on the cutting edge of both research and patient care. Now their associate...

Preparing a clinical trial budget is always seen as a long and taxing process- with so many complicated costs to consider, it's no wonder study budgeting has developed such a bad reputation. However, with the right resources walking you through the clinical trial...

 Principia Biopharma Inc. (PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology, today announced updates to its immune thrombocytopenia (ITP)...

CRO fulfills sponsor requests for real-time data analytics and visualization across studies. PROMETRIKA, LLC and Comprehend Systems, Inc. are proud to announce a partnership that will provide innovative solutions to meet the evolving needs of biotech and...

Circuit Clinical™ is proud to announce the addition of Craig Lipset to the Empirican Group Inc. Board of Directors. Circuit Clinical Logo (PRNewsfoto/Circuit Clinical) More "We are honored and thrilled Craig has joined our board," said Dr. Irfan Khan, CEO of Circuit...

Proven artificial intelligence (AI)-driven software now available as a self-service solution for biopharma companies Novel tool enables cutting trial participant enrollment time by up to 40% Phesi, a data-driven provider of premier integrated clinical development...

PARAGON study narrowly misses statistical significance on the primary endpoint; overall safety profile confirmed Totality of evidence suggests potential clinically important benefit; results will be presented in September at the ESC Congress 2019, the annual meeting...

As technology evolves our world, it's making the globe seem smaller and smaller every day. The trend of globalization is affecting nearly every industry, and the clinical trials industry is no exception. However, as clinical trials expand away from their home shores,...